Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice
about
An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia.The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting.Use of biologic agents in combination with other therapies for the treatment of psoriasisPatient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis.Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients.The MARCOPOLO Study of Ustekinumab Utilization and Efficacy in a Real-World Setting: Treatment of Patients with Plaque Psoriasis in Asia-Pacific Countries.Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.Improvements in patient-reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE.An evolution in switching therapy for psoriasis patients who fail to meet treatment goals.Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature.Using qualitative methods to understand factors contributing to patient satisfaction among dermatology patients: a systematic review.Time, PASI and DLQI of psoriasis patients who "drop out" of clinical trials on etanercept due to "lack of efficacy" - a pooled analysis from ten clinical trials.Reformulations of well-known active ingredients in the topical treatment of psoriasis vulgaris can improve clinical outcomes for patients.A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study.Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian study.Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial.Treatment preferences for biologicals in psoriasis: experienced patients appreciate sustainability.Perception of psoriasis treatment in the outpatient setting: survey of patients and their prescribing physicians.Redefining the therapeutic objective in psoriatic patients candidates for biological therapy.A multileveled approach in psoriasis assessment and follow-up: A proposal for a tailored guide for the dermatological practice.Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.Phototherapy of Psoriasis, a Chronic Inflammatory Skin Disease.Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability.
P2860
Q33431970-BD6734FD-9C7C-4AF3-93B5-EA058AD9712DQ33572834-C827FFF4-BFC1-46A8-9D6A-D7E0A84D6D83Q34196035-697892A9-5A4B-4A05-AEFF-840D32BFCBE6Q34553755-2729117C-075B-4760-B98E-DAD8E8F02F24Q35766545-441A8EB8-A52D-452A-A2E1-CA9D66E52F98Q35860158-EB3A893C-8199-4A0A-803F-0530004F7B1BQ35990756-3FEC01C3-1900-4111-87BD-8CEAA7DF58D4Q36628064-2C97D3B6-AF1C-411C-AD65-CC535B66BD4AQ37257450-B7BADB02-96C7-4D23-AA41-E69F5424FF1FQ37295966-9C407866-ADEA-4633-8541-900D29B79949Q37427086-7A5DB102-AC82-4DD3-BE47-1AB80F4A704DQ38619692-4393BE5E-C3B2-4630-9C77-CCEEB44306E9Q38644270-65A27757-5883-4740-B239-6F3DBED02C6DQ39248590-9399E3F5-B09F-4CEE-9E3E-B6D9997BE530Q39601823-D53E5B42-9D1F-4366-A466-A1418497CA90Q40046329-19685737-FF59-47AD-A1E4-B625B17378D1Q40132474-29D5FCD9-4F47-4CD4-8A92-DE6DECBB8232Q42646805-56E7C1AA-F818-473A-84BA-37CB73D129A2Q47667333-B756FA8E-4292-4162-8D10-4A2655A97F4FQ48368354-9AE180EF-11BE-4492-A241-7280006C1983Q48522422-C655831F-E29B-4D7A-8EA9-4A25849BF3F3Q49985388-638C0AB5-370E-4256-A32D-634C30F09115Q50074891-762747A9-438C-4BA1-BF11-C71B97E51B08Q53828883-AE2650D0-C0EF-48FD-BA45-E4C310A55AC2Q55119166-93114A88-4F47-4064-A411-348FCF6E1411
P2860
Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Patient satisfaction with trea ...... psoriasis in clinical practice
@ast
Patient satisfaction with trea ...... psoriasis in clinical practice
@en
Patient satisfaction with trea ...... psoriasis in clinical practice
@nl
type
label
Patient satisfaction with trea ...... psoriasis in clinical practice
@ast
Patient satisfaction with trea ...... psoriasis in clinical practice
@en
Patient satisfaction with trea ...... psoriasis in clinical practice
@nl
prefLabel
Patient satisfaction with trea ...... psoriasis in clinical practice
@ast
Patient satisfaction with trea ...... psoriasis in clinical practice
@en
Patient satisfaction with trea ...... psoriasis in clinical practice
@nl
P2093
P2860
P50
P356
P1476
Patient satisfaction with trea ...... psoriasis in clinical practice
@en
P2093
A D Robertson
A S Van Voorhees
G G Krueger
J Takeshita
K Callis Duffin
P2860
P304
P356
10.1111/BJD.12745
P407
P577
2014-03-01T00:00:00Z